1. Home
  2. ELTX vs JRSH Comparison

ELTX vs JRSH Comparison

Compare ELTX & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$5.35

Market Cap

68.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
JRSH
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
68.8M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
ELTX
JRSH
Price
$2.18
$5.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$18.00
$4.00
AVG Volume (30 Days)
266.2K
90.3K
Earning Date
05-12-2026
02-09-2026
Dividend Yield
N/A
5.68%
EPS Growth
39.29
485.71
EPS
N/A
0.13
Revenue
$2,301,000.00
$166,263,870.00
Revenue This Year
N/A
$11.64
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
$41.23
Revenue Growth
N/A
14.03
52 Week Low
$2.34
$2.85
52 Week High
$16.00
$5.81

Technical Indicators

Market Signals
Indicator
ELTX
JRSH
Relative Strength Index (RSI) 24.01 51.33
Support Level N/A $3.01
Resistance Level $3.32 $5.47
Average True Range (ATR) 0.13 0.21
MACD -0.03 -0.05
Stochastic Oscillator 1.09 28.36

Price Performance

Historical Comparison
ELTX
JRSH

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: